Case Report

A Rare Appendix Fibromatosis Mimicking a Gastrointestinal Stromal Tumor: A Case Report


  • Elbrus Zarbaliyev
  • Murat Sevmiş
  • Payam Hacısalihoğlu
  • Serap Baş
  • Mehmet Çağlıkülekçi

Received Date: 17.03.2021 Accepted Date: 30.04.2021 Turk J Colorectal Dis 2021;31(3):272-274

A 46-year-old male patient with an abdominal pain complaint and a palpable abdominal mass applied to our general surgery outpatient clinic. The computed tomography revealed a well-circumscribed solid mass, approximately 12 cm in diameter, which is thought to be a gastrointestinal stromal tumor originating from the cecum. The colonoscopy detected an external pressure on the cecum. No remarkable feature was noted in the patient’s history. Right hemicolectomy was performed. Pathological examination revealed a collagen-rich hypocellular mesenchymal tumor originating from the appendiceal wall, which was negatively stained with CD117 and DOG-1 immunohistochemical antibodies. The histopathological diagnosis revealed a fibromatous lesion (desmoid tumor). The patient was discharged on postoperative day 6 and was transferred to the oncology service.

Keywords: Appendix tumor, desmoid tumor, intraperitoneal fibromatosis, intraabdominal mass


Desmoid tumors are fibromatous masses with an incidence of 2-4/1,000,000 per year, which are histologically composed of spindle cells abundantly surrounded by collagen.1,2 Surrounding tissue invasion and after resection recurrence is seen but does not metastasize in desmoid tumors.1,3 Desmoid tumors are seen in different parts of the body; however, intraperitoneal desmoid tumors are very rare. Thirty percent of the intraperitoneal desmoid tumors occur sporadically in the mesentery root or pelvis. These tumors develop in patients with familial adenomatous polyposis (FAP), Gardner syndrome, and adenomatous polyposis coli (APC) mutation.1,2,4 Studies reported that desmoid tumors developed following gastrointestinal stromal tumors (GISTs) resection.4 Other more common intraperitoneal masses should be considered in the differential diagnosis before desmoid tumors in patients with palpable mass and compression symptoms. Surgery is primarily preferred for intraperitoneal desmoid tumor treatment; however, resection is impossible in some cases.5,6 Presented herein is a 46-year-old male patient who underwent right hemicolectomy with a preliminary diagnosis of GIST and had a pathological diagnosis of an appendiceal desmoid tumor.

Case Report

A 46-year-old male patient complained of a right lower quadrant mass. The intravenous contrast-enhanced abdominal computed tomography (CT) revealed a well-circumscribed mass, 12 cm in diameter, with smooth borders originating from the cecum. (Figure 1a). The patient’s tumor markers were within normal limits. A colonoscopy was performed and no feature was observed in the cecum other than the external compression. A positron emission tomography (PET)/CT was performed with Fluorine-18 Fluorodeoxyglucose (F18-FDG). The Maximum standard unit value of the mass was 6.29. (Figure 1b). The patient applied to our clinic for surgery and was operated with a pre-diagnosis of GIST of cecal origin. During the surgery, the mass was observed to be localized in the ileocecal region, which caused traction to the right ureter (Figure 2). Right hemicolectomy and ileotransversostomy were performed. Pathological macroscopic examination revealed a mass originating from the appendiceal wall. Microscopic interpretation revealed a hypocellular mesenchymal collagen-rich tumor. The tumor was negative with CD117, CD34, desmin, calretinin (-), and S-100, and positive with cyclin D-1, b-catenin, and androgen receptor, immunohistochemically. Ki-67 proliferation index of the tumor was 3%-4%. The tumor was diagnosed as fibromatosis (desmoid tumor) (Figure 3). The patient was discharged without any complications on postoperative day 5.


Desmoid tumor is a rare mesenteric neoplasm with fibromatous features.1 It is a fibroblastic/myofibroblastic tumor, originating from the musculoaponeuroic structures, arising in deep soft tissues.1,7 Desmoid tumors can be observed in different parts of the body.1,8 Gardner syndrome, FAP, APC, unopposed estrogen, and previous surgeries are known risk factors.6 Basic histological features of desmoid tumors are spindle cells and fibroblasts surrounded by abundant collagen. Its morphological features sometimes mimic GIST; however, it does not immunohistochemically express either CD117 or DOG-1.1,3,9

Extra-abdominal masses are detected earlier; however, desmoid tumors located intra-abdominally are later presented.5 Intraperitoneal desmoid tumors without specific findings are usually detected due to signs of pressure on adjacent organs and as palpable masses. In our case, the patient’s only complaint was a palpable mass at the time of admission. Desmoid tumors are the most common mesenteric primary tumor but are very rare in the gastrointestinal system. Cases located in the pancreas, stomach, small intestine, colon, and appendix with different findings were reported in the literature.1,4,10 Intraperitoneal desmoid tumors are often confused with GIST before resection, and definitive diagnosis can only be made with tissue biopsies.3 Desmoid tumors can mimic local recurrence after GIST resection.4

Desmoid tumors of the appendix are very rare and only a few cases were reported. These tumors, seen as masses in the cecal region, rarely cause acute appendicitis by occluding the appendiceal lumen and are sometimes confused as periapendicular abscess.11,12 GIST is often suspected since they present as well-circumscribed solid masses originating from the cecum in preoperative evaluations.3,4 In our case, a similar pre-diagnosis was considered and the decision for surgery was made.

CT and magnetic resonance imaging are the preferred diagnostic imaging methods.1,3 Endoscopy demonstrates compression from the outside or protrusion into the lumen due to the mass effect. Percutaneous tissue biopsy is performed for differential diagnosis in patients with unresectable tumors. PET/CT is rarely used to diagnose desmoid tumors and is generally recommended in patient follow-ups for recurrence.6,13 In our case, F18-FDG involvement was determined by PET/CT.

A multidisciplinary approach is very important in desmoid tumor treatment originating from the gastrointestinal system. Active follow-up together with chemotherapy and radiotherapy (RT) provides a 5-year survival rate of 50% in desmoid tumors.6 Resection is the first choice of treatment for intraperitoneal desmoid tumors.1,2,4 Resection with negative surgical margins should be considered due to local recurrence possibility. The recurrence rates in intraperitoneal tumors are relatively low although 20% recurrence has been reported in desmoid tumors with negative surgical margins.6 Chemotherapy is considered when tumor removal is impossible and as recurrence prevention after resection.2,6 The use of RT together with surgical treatment was reported to be more successful than surgical treatment alone.14 In our case, a right hemicolectomy was performed due to the presence of a cecum-derived tumoral mass. The patient was transferred to the oncology center for chemotherapy and RT.

In conclusion, desmoid tumors are rarely seen in the entire gastrointestinal system, including the appendix. Multidisciplinary treatment should be adopted and patients should be closely followed. These tumors mimicking GIST have high recurrence rates. Therefore, care should be taken in surgical treatment and negative surgical resection margins should be provided to prevent a recurrence.


Informed Consent: Was obtained from the patient.

Peer-review: Externally peer reviewed.

Authorship Contributions

Surgical and Medical Practices: E.Z., M.Ç., Concept: E.Z., M.Ç., Design: E.Z., M.Ç., Data Collection or Processing: E.Z., M.S., P.H., S.B., M.Ç., Analysis or Interpretation: E.Z., M.S., P.H., S.B., M.Ç., Literature Search: E.Z., M.S., P.H., M.Ç., Writing: E.Z., P.H.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study received no financial support.


  1. Shinagare AB, Ramaiya NH, Jagannathan JP, Krajewski KM, Giardino AA, Butrynski JE, Raut CP. A to Z of desmoid tumors. AJR Am J Roentgenol 2011;197:W1008-1014.
  2. Napolitano A, Mazzocca A, Spalato Ceruso M, Minelli A, Baldo F, Badalamenti G, Silletta M, Santini D, Tonini G, Incorvaia L, Vincenzi B. Recent advances in desmoid tumor therapy. Cancers (Basel) 2020;12:2135.
  3. Wong SL. Diagnosis and management of desmoid tumors and fibrosarcoma. J Surg Oncol 2008;97:554-558.
  4. Kim JH, Ryu MH, Park YS, Kim HJ, Park H, Kang YK. Intra-abdominal desmoid tumors mimicking gastrointestinal stromal tumors - 8 cases: a case report. World J Gastroenterol 2019;25:2010-2018.
  5. Bertagnolli MM, Morgan JA, Fletcher CD, Raut CP, Dileo P, Gill RR, Demetri GD, George S. Multimodality treatment of mesenteric desmoid tumours. Eur J Cancer 2008;44:2404-2410.
  6. Desmoid Tumor Working Group. The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients. Eur J Cancer 2020;127:96-107.
  7. Zreik RT, Fritchie KJ. Morphologic Spectrum of Desmoid-Type Fibromatosis. Am J Clin Pathol 2016;145:332-340.
  8. Keskin M, Üçüncü MZ, Memişoğlu E, Bayraktar A, Balık E, Bulut MT. Our experience with desmoid tumors. Turk J Colorectal Dis 2016;26:90-97.
  9. Chu Y, Guo Q, Wu D. Mesenteric fibromatosis after resection for gastrointestinal stromal tumor of stomach: A case report. Medicine (Baltimore) 2017;96:e8792.
  10. Asenov Y, Genadiev S, Timev A, Panaiotova J, Hadjiiska V, Veselin T, Sedloev T. Ruptured desmoid tumor imitating acute appendicitis - a rare reason for an emergency surgery. BMC Surg 2019;19:194.
  11. Bravo-Taxa M, Vásquez-Vásquez CL, López-Blanco A, Taxa-Rojas L. Fibromatosis tipo desmoide de apéndice cecal: reporte de caso inusual y revisión de la literatura [Appendicular desmoid tumor: unusual case and review of the literature]. Rev Gastroenterol Peru 2020;40:193-197. (Spanish)
  12. Peled Z, Linder R, Gilshtein H, Kakiashvili E, Kluger Y. Cecal fibromatosis (desmoid tumor) mimicking periappendicular abscess: a case report. Case Rep Oncol 2012;5:511-514.
  13. Basu S, Nair N, Banavali S. Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: potential clinical role of FDG-PET in the management. Br J Radiol 2007;80:750-756.
  14. Nuyttens JJ, Rust PF, Thomas CR Jr, Turrisi AT 3rd. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer 2000;88:1517-1523.